CAMP4 Therapeutics (CAMP)
Antisense RNA medicines designed to restore protein expression in genetic diseases.
$3.83
Pre-market+0.03 (+0.79%)
At close$3.80(+0.26%)
Something off on this page? Send us feedback.
EPSReportedEstimate
Nov '24Mar '25May '25Aug '25Nov '25Mar '26May '26Aug '26
Reported−$24.19−$2.83−$0.62−$0.62−$0.55−$0.87−$0.32−$0.58
Estimate−$1.07−$0.91−$0.70−$0.67−$0.47−$0.31−$0.21−$0.21
Surprise−2,153.6%−211.0%+11.4%+7.5%−17.0%−180.6%−52.4%−174.3%
RevenueReportedEstimate
Nov '24Mar '25May '25Aug '25Nov '25Mar '26May '26Aug '26
Reported—$652.0K$858.0K$1.5M$795.0K$300.0K$1.3M$1.8M
Estimate$250.0K$33.3K$420.2K$128.0K$433.3K$475.2K$1.1M$1.6M
Surprise—+1,856.2%+104.2%+1,069.5%+83.5%−36.9%+15.7%+9.8%
History
| Date | Estimate | Reported | Surprise |
|---|---|---|---|
| Aug 2026 | −$0.21 | −$0.58 | −174.3% |
| May 2026 | −$0.21 | −$0.32 | −52.4% |
| Mar 2026 | −$0.31 | −$0.87 | −180.6% |
| Nov 2025 | −$0.47 | −$0.55 | −17.0% |
The latest year is open to everyone — the 42 quarters behind it read with an account. Sign in | |||
| Aug 2025 | |||
| May 2025 | |||
| Mar 2025 | |||
| Nov 2024 | |||
| Jul 2024 | |||
| Jun 2024 | |||
| Jan 2024 | |||
| Oct 2023 | |||
| Jul 2023 | |||
| Apr 2023 | |||
| Dec 2022 | |||
| Sep 2022 | |||
| Jun 2022 | |||
| Apr 2022 | |||
| Dec 2021 | |||
| Sep 2021 | |||
| Jun 2021 | |||
| Apr 2021 | |||
| Dec 2020 | |||
| Sep 2020 | |||
| Jun 2020 | |||
| May 2020 | |||
| Dec 2019 | |||
| Sep 2019 | |||
| Jun 2019 | |||
| Apr 2019 | |||
| Dec 2018 | |||
| Sep 2018 | |||
| Jun 2018 | |||
| Apr 2018 | |||
| Dec 2017 | |||
| Sep 2017 | |||
| Jun 2017 | |||
| Apr 2017 | |||
| Dec 2016 | |||
| Sep 2016 | |||
| Jun 2016 | |||
| Apr 2016 | |||
| Oct 2015 | |||
| Jun 2015 | |||
| Apr 2015 | |||
| Oct 2014 | |||
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Aug 13, 2026 | −$0.21 | −$0.58 | −174.3% | $1.6M | $1.8M | +9.8% | +20.9% |
| May 7, 2026 | −$0.21 | −$0.32 | −52.4% | $1.1M | $1.3M | +15.7% | +2.8% |
| Mar 5, 2026 | −$0.31 | −$0.87 | −180.6% | $475.2K | $300.0K | −36.9% | −8.5% |
| Nov 6, 2025 | −$0.47 | −$0.55 | −17.0% | $433.3K | $795.0K | +83.5% | −4.5% |
The latest year is open to everyone — the 42 quarters behind it read with an account. Sign in | |||||||
| Aug 14, 2025 | |||||||
| May 13, 2025 | |||||||
| Mar 27, 2025 | |||||||
| Nov 21, 2024 | |||||||
| Jul 8, 2024 | |||||||
| Jun 6, 2024 | |||||||
| Jan 9, 2024 | |||||||
| Oct 5, 2023 | |||||||
| Jul 10, 2023 | |||||||
| Apr 27, 2023 | |||||||
| Dec 20, 2022 | |||||||
| Sep 22, 2022 | |||||||
| Jun 23, 2022 | |||||||
| Apr 28, 2022 | |||||||
| Dec 21, 2021 | |||||||
| Sep 23, 2021 | |||||||
| Jun 24, 2021 | |||||||
| Apr 22, 2021 | |||||||
| Dec 17, 2020 | |||||||
| Sep 24, 2020 | |||||||
| Jun 25, 2020 | |||||||
| May 5, 2020 | |||||||
| Dec 19, 2019 | |||||||
| Sep 26, 2019 | |||||||
| Jun 27, 2019 | |||||||
| Apr 30, 2019 | |||||||
| Dec 20, 2018 | |||||||
| Sep 27, 2018 | |||||||
| Jun 27, 2018 | |||||||
| Apr 26, 2018 | |||||||
| Dec 21, 2017 | |||||||
| Sep 28, 2017 | |||||||
| Jun 27, 2017 | |||||||
| Apr 18, 2017 | |||||||
| Dec 21, 2016 | |||||||
| Sep 29, 2016 | |||||||
| Jun 28, 2016 | |||||||
| Apr 19, 2016 | |||||||
| Oct 1, 2015 | |||||||
| Jun 30, 2015 | |||||||
| Apr 21, 2015 | |||||||
| Oct 6, 2014 | |||||||